Non-Alcoholic Fatty Liver Disease in HIV Infection Associated with Altered Hepatic Fatty Acid CompositionBianca M. Arendt, Johane P. Allard, Saira Mohammed et al.|Current HIV Research|2011Cited by 16
Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG‐IFN α‐2a (40KD) (PEGASYS<sup>®</sup>)Brian Bressler, E. Jenny Heathcote, Joseph F. Grippo et al.|British Journal of Clinical Pharmacology|2009Cited by 15